Kim Forest Enterprise Co., Ltd. (TPE:6645)
Taiwan · Delayed Price · Currency is TWD 12.20
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
Kim Forest Enterprise Market Cap
Kim Forest Enterprise has a market cap or net worth of 736.68 million as of September 8, 2026. Its market cap has decreased by -48.07% in one year.
Market Cap
736.68M
Enterprise Value
1.13B
Revenue
599.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.20
ChartMarket Cap Chart
Since August 18, 2017, Kim Forest Enterprise's market cap has increased from 545.05M to 736.68M, an increase of 35.16%. That is a compound annual growth rate of 3.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 736.68M | -31.35% |
| Dec 31, 2025 | 1.07B | -16.65% |
| Dec 31, 2024 | 1.29B | -24.16% |
| Dec 29, 2023 | 1.70B | 21.03% |
| Dec 30, 2022 | 1.40B | 32.47% |
| Dec 30, 2021 | 1.06B | -29.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.91B |
| Puriblood Medical | 1.07B |
| Genetics Generation Advancement | 1.05B |
| Sofiva Genomics | 736.33M |
| TFBS Bioscience | 663.84M |
| Welgene Biotech | 379.86M |
| Pharmigene | 368.90M |